Nabil Asaad, PhD

Senior Associate

Nabil Asaad, PhD

Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance. In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry.

Show full CV Hide full CV

Latest news & insights

Interface - Quantum computing - the next really big thing

Using quantum computing in life sciences

Nabil Asaad looks at the potential for quantum computing to revolutionise life sciences.

14 March 2022

by Nabil Asaad, PhD

2 of 4 Insights

Click here to find out more
Laboratory pipettes
Life sciences & healthcare

Advising IP Group on option exercise to accelerate development of first-in-class gene therapy for patients with cystic fibrosis

29 October 2021

by Colin McCall and Nabil Asaad, PhD

Click here to find out more
White microscope on yellow background

Recognition for our expertise as Life Sciences Team of the Year

24 November 2022

by multiple authors

Click here to find out more
Patents & innovation

LIVE STREAM - The UPC: How to use it, not use it and some problems

17 November 2022

by multiple authors

Click here to find out more

Related people

Meet me at

There are no upcoming events